Gigantul Nestle vrea să dezvolte noi produse alimentare pentru utilizatorii de medicamente pentru slăbit - Economica.net

Nestlé aims to leverage the rise of GLP-1 weight loss drugs as a business opportunity by developing tailored products using AI and nutritional science. The company is focusing on creating solutions for consumers experiencing rapid weight loss effects, while also addressing potential nutrient deficiencies. Nestlé's technology director highlighted the use of AI to analyze clinical studies and consumer responses, aiming to enhance product development. However, some nutrition experts question the necessity and cost-effectiveness of specialized products compared to whole foods.